Its expression is substantially elevated during oxidative stress, and this upregulation of LCN2 is usually associated with a compensatory defense mechanism against pathogens that were able to overcome the impaired mucosal barrier that is seen in IBD [31]. This evidence concerns the gene LCN2 and inflammatory bowel disease.